ABVX
AbivaxDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
9
U.S. public peers
Grade Position
Below peers
vs peer average
ABVX vs peer average
39/100
ABVX vs. peer average (D vs. C)
Grade spread
B 3 · C 3 · F 3
Graded peers loaded
Coverage
9 graded
100% of tracked
Peer overview
PCVX is the first available peer comparator.
Development-stage biotech of similar packet market capitalization, but its vaccine programs are not direct ulcerative-colitis comparators; market-cap similarity is not a valuation multiple.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ABVX
Abivax
PCVX
Vaxcyte
Grade
D
C
Momentum
18
91
Value
41
41
Sentiment
66
56
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Mixed
Grade position vs PCVX
ABVX / PCVX
Grade Position
Below peers
ABVX vs. peer average (D vs. C)
39/100
Momentum
18
PCVXValue
41
ABVXSentiment
66
ABVXRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ABVX
PCVX is the first peer returned for this comparison set.